Related references
Note: Only part of the references are listed.Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus
Caroline von Spee-Mayer et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus
Jing He et al.
NATURE MEDICINE (2016)
Engagement of SLAMF3 enhances CD4+ T-cell sensitivity to IL-2 and favors regulatory T-cell polarization in systemic lupus erythematosus
Denis Comte et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Rapid induction of clinical remission by low-dose interleukin-2 in a patient with refractory SLE
Jens Y. Humrich et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Interleukin-2 at the Crossroads of Effector Responses, Tolerance, and Immunotherapy
Wei Liao et al.
IMMUNITY (2013)
SPICE: Exploration and Analysis of Post-Cytometric Complex Multivariate Datasets
Mario Roederer et al.
CYTOMETRY PART A (2011)
Inflammatory Cytokines in Systemic Lupus Erythematosus
Kim Ohl et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
The Dysregulation of Cytokine Networks in Systemic Lupus Erythematosus
Sokratis A. Apostolidis et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2011)
MECHANISMS OF DISEASE Systemic Lupus Erythematosus
George C. Tsokos
NEW ENGLAND JOURNAL OF MEDICINE (2011)
IL-2 Family of Cytokines in T Regulatory Cell Development and Homeostasis
Thomas R. Malek et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2008)
Interleukin 2: from immunostimulation to immunoregulation and back again
Martin F. Bachmann et al.
EMBO REPORTS (2007)
Share Paper
